Liraglutide and Renal Outcomes in Type 2 Diabetes - PubMed (original) (raw)

Comment

. 2017 Nov 30;377(22):2195.

doi: 10.1056/NEJMc1713042.

Affiliations

Comment

Liraglutide and Renal Outcomes in Type 2 Diabetes

Lennart Tonneijck et al. N Engl J Med. 2017.

No abstract available

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Buse JB. Mann JFE, et al. N Engl J Med. 2017 Nov 30;377(22):2197-2198. doi: 10.1056/NEJMc1713042. N Engl J Med. 2017. PMID: 29171823 No abstract available.

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Clinical Trial.

Slowing the Progression of Diabetic Kidney Disease.
Blazek O, Bakris GL. Blazek O, et al. Cells. 2023 Jul 31;12(15):1975. doi: 10.3390/cells12151975. Cells. 2023. PMID: 37566054 Free PMC article. Review.
Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice.
Morieri ML, Avogaro A, Fadini GP. Morieri ML, et al. Diabetes Metab Syndr Obes. 2020 Nov 9;13:4221-4234. doi: 10.2147/DMSO.S216054. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 33204129 Free PMC article. Review.